NLS Pharmaceutics's total assets for Q were $1.85M, a decrease of -80.09% from the previous quarter. NLSP total liabilities were $10.68M for the fiscal quarter, a 78.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.